Callipeltin A, a Cyclic Depsipeptide Inhibitor of the Cardiac Sodium–Calcium Exchanger and Positive Inotropic Agent

Callipeltin A, a cyclic depsipeptide from the New Caledonian Lithistida sponge Callipelta sp., is a macrocyclic lactone containing four amino acids in the L configuration, Ala, Leu, Thr (2 residues); one (Arg) in the D configuration; two N-methyl amino acids, N-MeAla and N-MeGln; a methoxy tyrosine,...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 279; no. 1; pp. 219 - 222
Main Authors Trevisi, L., Bova, S., Cargnelli, G., Danieli-Betto, D., Floreani, M., Germinario, E., D'Auria, M.V., Luciani, S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 09.12.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Callipeltin A, a cyclic depsipeptide from the New Caledonian Lithistida sponge Callipelta sp., is a macrocyclic lactone containing four amino acids in the L configuration, Ala, Leu, Thr (2 residues); one (Arg) in the D configuration; two N-methyl amino acids, N-MeAla and N-MeGln; a methoxy tyrosine, a 3,4-dimethyl-l-glutamine; and a 4-amino-7-guanidino-2,3 dihydroxypentanoic acid (AGDHE), formally derived from L-Arg. In cardiac sarcolemmal vesicles Callipeltin A induces a powerful (IC50 = 0.85 μM) and selective inhibition of the Na+/Ca2+ exchanger. In electrically driven guinea-pig atria, at concentrations ranging between 0.7 and 2.5 μM, Callipeltin A induces a positive inotropic effect, which at the highest concentrations is accompanied by a rise in resting tension. It is suggested that the positive inotropic effect is linked to the inhibition of the Na+/Ca2+ exchanger and that Callipeltin A may be an useful tool to study the role of the cardiac Na+/Ca2+ exchanger in physiological and pathological conditions.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0006-291X
1090-2104
DOI:10.1006/bbrc.2000.3906